Daily Endocrinology Research Analysis
Analyzed 53 papers and selected 3 impactful papers.
Summary
Analyzed 53 papers and selected 3 impactful articles.
Selected Articles
1. Cognitive Behavioral Interventions for Children and Adolescents With Overweight or Obesity: A Systematic Review and Component Network Meta-Analysis.
Across 125 RCTs (16,513 participants), behavioral therapy reduced body fat percentage and waist circumference and improved quality of life versus minimal education. Parental involvement and stimulus control reduced BMI z-score, while preplanning and feedback lowered body fat percentage; notably, device monitoring, problem-solving, rule-setting, and relaxation training might increase body fat percentage.
Impact: This component-level synthesis identifies the most effective CBT techniques for pediatric obesity, enabling targeted, efficient program design rather than one-size-fits-all interventions.
Clinical Implications: Prioritize parental involvement, stimulus control, preplanning, and feedback in pediatric obesity programs; be cautious with device monitoring and similar components that may worsen adiposity; integrate these findings into multidisciplinary care and guideline updates.
Key Findings
- Behavioral therapy reduced body fat percentage (MD −1.16%) and waist circumference (MD −1.70 cm) and improved quality of life versus minimal education.
- Parental involvement and stimulus control probably reduced BMI z-score compared with minimal education.
- Preplanning and feedback probably reduced body fat percentage, whereas device monitoring, problem-solving, rule-setting, and relaxation might increase it.
Methodological Strengths
- Component network meta-analysis across 125 RCTs with 16,513 participants enables disentangling effects of individual CBT techniques.
- Certainty of evidence appraised using modified GRADE approaches.
Limitations
- Heterogeneity in interventions, comparators, and outcome measurements across trials.
- Some components were informed by a limited number of studies, increasing imprecision and indirectness.
Future Directions: Prospective head-to-head factorial trials to validate prioritized components and optimize sequencing and dose; implementation studies to integrate effective components into real-world multidisciplinary programs.
BACKGROUND: The efficacy of individual cognitive behavioral therapy (CBT) components for managing pediatric obesity remains unclear. This study systematically evaluated the impacts of CBT and its constituent techniques in this population. METHOD: We searched PubMed, Embase, and Cochrane CENTRAL from inception to July 17, 2024, for randomized controlled trials comparing CBT techniques or usual care targeting obesity management in children and adolescents with overweight or obesity. Component network meta-analyses provided
2. A simple and robust reporter-based framework for deep functional characterization of PPARγ mutants.
The authors establish four complementary reporter assays to independently assess full-length transactivation, LBD integrity, heterodimerization, and DNA binding of PPARγ. Applied to three FPLD3 loss-of-function and two bladder cancer gain-of-function variants, the framework yielded distinct functional fingerprints corroborated by co-regulator profiling, offering a scalable approach to variant interpretation across nuclear receptors.
Impact: Provides an accessible, mechanistically informative toolkit to functionally validate PPARG variants, addressing a key gap in variant classification and enabling translational genomics in endocrine-metabolic disorders.
Clinical Implications: Supports faster and more accurate classification of PPARG variants (e.g., in suspected lipodystrophy) to inform diagnosis, counseling, and potential precision therapies; framework is adaptable to other nuclear receptors relevant to endocrine oncology.
Key Findings
- Developed four reporter assays capturing full-length transactivation, LBD integrity, heterodimerization, and DNA binding of PPARγ.
- Identified unique functional phenotypes for three FPLD3 loss-of-function and two bladder cancer gain-of-function variants.
- Co-regulator profiling corroborated assay-derived phenotypes, supporting mechanistic resolution and scalability.
Methodological Strengths
- Orthogonal, complementary assays reduce false inference and provide modular mechanistic insights.
- Demonstrated applicability across distinct clinical variant classes with co-regulator validation.
Limitations
- Preclinical, in vitro framework without in vivo validation or clinical outcome correlation.
- Evaluated a limited number of variants; large-scale benchmarking against high-throughput datasets is pending.
Future Directions: Expand to larger variant libraries, integrate with clinical databases for ACMG/AMP evidence weighting, and adapt the framework to other nuclear receptors to standardize functional genomics pipelines.
Missense mutations in nuclear receptors (NR) transcription factors (TF) cause a number of genetic disorders, including PPARG mutations that result in familial partial lipodystrophy type 3 (FPLD3). Experimental assessment is essential to establish a newly identified mutation as disease-causing, as accurately predicting the effect of new mutation in silico remains challenging due to the multifunctional and modular nature of these proteins. However, deep structure-function characterisation often requires
3. Development and Validation of Nomogram-Based Predictive Models for Severe Hypoglycemia in Adults With Type 1 Diabetes Treated With Multiple Daily Injections: The SEHYPAN Study.
In 1,464 adults with T1D on MDI, two nomogram models were developed: an overall model (monitoring modality, prior severe/nocturnal hypoglycemia, depression, alcohol use, chronic conditions) and an isCGM-specific model adding time in range and time below range. isCGM use independently associated with lower odds of severe hypoglycemia, and both models achieved AUC 0.75–0.83 with high sensitivity.
Impact: Delivers practical, individualized risk tools to target preventive strategies and CGM deployment for adults with T1D on MDI, addressing a major safety gap in routine care.
Clinical Implications: Use the nomograms to flag high-risk individuals for education, CGM adoption, and tailored glycemic targets; consider depression and alcohol use in risk counseling; reinforce isCGM benefits for hypoglycemia prevention.
Key Findings
- Two nomogram-based models predicted severe hypoglycemia with AUC 0.75–0.83 and high sensitivity.
- isCGM use independently associated with lower odds of severe hypoglycemia in the full cohort model.
- Risk factors included prior severe/nocturnal hypoglycemia, depression, alcohol use, and chronic conditions; TIR and TBR improved prediction in isCGM users.
Methodological Strengths
- Large multicenter case-control design with matched controls and inclusion of CGM-derived metrics.
- Nomogram development with good discrimination and clinically interpretable predictors.
Limitations
- Case-control design limits causal inference and may be prone to residual confounding.
- External validation and generalizability beyond the regional cohort remain to be established.
Future Directions: Prospective external validation and model updating in diverse settings; integration into EHRs for automated risk alerts; testing whether targeted interventions guided by the nomogram reduce severe hypoglycemia.
BACKGROUND: Severe hypoglycemia is a major acute complication of type 1 diabetes (T1D) and is associated with increased morbidity, mortality, and impaired quality of life. Identifying individuals at the highest risk remains essential for optimising preventive strategies in real-world practice. METHODS: The SEHYPAN (SEvere HYpoglycemia in ANdalusia) study was a multicenter case-control analysis including adults with T1D treated with multiple daily insulin injections (MDI). Cases were individuals who